ecteinascidin 743 has been researched along with Cells, Neoplasm Circulating in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaye, SB; Lebedinsky, CA; McCormack, R; Monk, BJ; Parekh, T; Poveda, A; Ricci, D; Tercero, JC; Wang, S; Zintl, P | 1 |
1 trial(s) available for ecteinascidin 743 and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Disease-Free Survival; Doxorubicin; Female; Humans; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Ovarian Neoplasms; Polyethylene Glycols; Survival Rate; Tetrahydroisoquinolines; Trabectedin | 2011 |